X
Xsphera Biosciences Inc
Precision ex vivo profiling to predict patient responses to oncology therapeutics
About Xsphera Biosciences Inc
Xsphera Biosciences Inc. specializes in predicting patient responses to oncology therapeutics using their advanced Tumor Microenvironment (TME) Platform. This platform preserves the complete tumor microenvironment from a biopsy, including immune cells, tumor cells, and stroma, within multiple microfluidic channels. Each channel can be treated with different therapies to measure cytotoxic efficacy and molecular response, providing a comprehensive analysis of therapeutic outcomes. The Intelligent Analytics platform integrates cloud-based software with laboratory environments to automatically ingest and analyze sample and treatment response data, including detailed patient immune profiles.
Xsphera Biosciences serves oncology researchers and pharmaceutical companies, operating in the precision medicine market. The business model is based on providing advanced profiling services and analytics to predict therapeutic responses, thus aiding in the development of personalized cancer treatments. Revenue is generated through service contracts with research institutions and pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 67.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, slush24, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2023 | $13M | $50M | Undisclosed | ↗ |
| SEEDEquity / VC | Nov 2020 | $5M | $20M | Undisclosed | — |
Growth signals
Latest recorded traffic for Xsphera Biosciences Inc is 1.7K monthly website visits, up 400% over the last three months. Xsphera Biosciences Inc's team declined 18.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Xsphera Biosciences Inc in the Cambridge ecosystem
The Xsphera Biosciences Inc office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Dana-Farber Cancer Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xsphera Biosciences Inc on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xsphera Biosciences Inc’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










